JACC-CARDIOVASC INTE 润色咨询

JACC-Cardiovascular Interventions

出版年份:2008 年文章数:1493 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2018-03-07 1ddccb01m45(暂无匿称)

    过两个星期没回复.说明在审稿了JessicaYu 2017-11-26 17:26:00 发表:
    32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT

    JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2017-11-26 JessicaYu

    审稿速度:2.0
    经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2017-10-26 1204b345m76(暂无昵称)

    接受case report 吗? 官网上说不接受---272560 2015-11-20 发表::
    研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.

    272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2017-07-16 13305510181

    涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2017-03-28 1ddccb01m45(暂无匿称)

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2016-10-20 qqd140d1b8

    怎么投啊,我也想投啊,教教我吧萤火 2016-10-07 发表::
    接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?

    萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2016-10-07 萤火3262

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2015-11-20 272560

    审稿速度:1.0
    经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2015-10-23 ruipinsu

    必然比JACC简单啊

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=553396, encodeId=e2ae553396e4, content=过两个星期没回复.说明在审稿了<span class="quote">JessicaYu 2017-11-26 17:26:00 发表:<br>32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT</span>, beContent=JessicaYu 2017-11-26 17:26:00 发表: 32天了还在under review.不知道什么时候能送外审..大家都是这样嘛求指导求经验TT, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Wed Mar 07 00:00:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549510, encodeId=bce054951093, content=审稿速度:2.0<br>经验分享:32天了还在under review,不知道什么时候能送外审。。大家都是这样嘛求指导求经验TT, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAhK9JoTYcniak6ThAhKX7z40M7pLnz6c66BLXia4OXh4giaDEGTyKS7KFXT7YIJOQ3TO9nYuNkZRBQ/132, createdBy=7fea2194390, createdName=JessicaYu, createdTime=Sun Nov 26 17:26:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548620, encodeId=6e3b548620b0, content=接受case report 吗? 官网上说不接受---<span class="quote">272560 2015-11-20 发表::<br>研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响.</span>, beContent=272560 2015-11-20 发表:: 研究方向:心血管; 审稿时间:约1个月 SCI(2013):7.44SCI(2014):7.34517/11/2015上午投的一个Case Report.19/11接收!当然是全世界首例报道.而且是在英国国家心肺研究所发的.估计也是有影响., objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86d2169245, createdName=1204b345m76(暂无昵称), createdTime=Thu Oct 26 16:17:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544376, encodeId=1b5c5443e644, content=涨就一个字,喜迎上涨.看这个势头,未来突破10分在望!我在安徽,能发一篇,满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13305510181, createdTime=Sun Jul 16 19:08:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534793, encodeId=31a3534e93d9, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:在上面投了一篇letter,投稿成功就显示under review,千万不要以为就送审了。大概过了15天就收到邮件说接收了。有人说编辑会每周定期开会决定文章是否送审,但是我等了2周,可能是刚好赶上ACC年会吧,主编去开会了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Tue Mar 28 14:34:00 CST 2017, time=2017-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528457, encodeId=911052845eb1, content=怎么投啊,我也想投啊,教教我吧<span class="quote">萤火 2016-10-07 发表::<br>接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?</span>, beContent=萤火 2016-10-07 发表:: 接收率:约25% 审稿时间:约1个月 投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6691734472, createdName=qqd140d1b8, createdTime=Thu Oct 20 19:19:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527959, encodeId=a8d952e959c9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投了一篇被拒了,很郁闷的是只显示结果而没有审稿意见,难道本杂志只显示审稿结果不给出原因吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/24/88ebd3eb6ee9a209ffc418bab00a7605.jpg, createdBy=b1441712901, createdName=萤火3262, createdTime=Fri Oct 07 20:31:00 CST 2016, time=2016-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516956, encodeId=3d6951695639, content=审稿速度:1.0<br>经验分享:17/11/2015上午投的一个Case Report,19/11接收!当然是全世界首例报道,而且是在英国国家心肺研究所发的,估计也是有影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=74681302641, createdName=272560, createdTime=Fri Nov 20 06:30:00 CST 2015, time=2015-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516256, encodeId=390f516256b1, content=必然比JACC简单啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f21293613, createdName=ruipinsu, createdTime=Fri Oct 23 10:58:00 CST 2015, time=2015-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511938, encodeId=ccc5511938bb, content=不知道和JACC比能不能简单一些呢? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=803248632, createdName=arlian1977, createdTime=Sun May 17 22:19:00 CST 2015, time=2015-05-17, status=1, ipAttribution=)]
    2015-05-17 arlian1977

    不知道和JACC比能不能简单一些呢?

    0

共27条页码: 2/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分